logo
ProjectForthcoming

Synthetic Multi-timepoint AI-enhanced Breast MRI

The status, timeline and source of this project. A free account opens every field.

Source: EU Funding & Tenders Portal

Smart-MRI (Synthetic Multi-timepoint AI-enhanced Breast MRI) aims to eliminate the need for gadolinium-based contrast agents while preserving the diagnostic accuracy of Dynamic Contrast-Enhanced MRI (DCE-MRI). Smart-MRI consists of three key phases. The first phase focuses on AI model optimization and external validation. Our deep learning model is trained on a large dataset of paired contrast-enh

Status
Prospective
Sector
Manufacturing (Industrial), Commercial, Residential
Location
Netherlands
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Synthetic Multi-timepoint AI-enhanced Breast MRI

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Synthetic Multi-timepoint AI-enhanced Breast MRI” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Netherlands. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Smart-MRI (Synthetic Multi-timepoint AI-enhanced Breast MRI) aims to eliminate the need for gadolinium-based contrast agents while preserving the diagnostic accuracy of Dynamic Contrast-Enhanced MRI (DCE-MRI). Smart-MRI consists of three key phases. The first phase focuses on AI model optimization and external validation. Our deep learning model is trained on a large dataset of paired contrast-enhanced and non-contrast breast MRI scans, designed to capture essential temporal and morphological features for lesion characterization. By reducing imaging complexity and relying only on pre-contrast T1-weighted and DWI sequences, Smart-MRI streamlines imaging protocols, supporting feasibility for widespread clinical adoption. The second phase involves a multi-center external validation in a screening setting to assess the generalizability and clinical applicability of Smart-MRI across different imaging systems and diverse patient populations. Structured reader studies are conducted with expert radiologists to compare Smart-MRI-generated synthetic contrast-enhanced images with standard DCE-MRI for this purpose. These studies evaluate lesion detectability, image fidelity, and diagnostic confidence. In the third, and overlapping phase, we assess market potential, and analyse barriers for integration into routine clinical practice, aiming to create an initial prospective integration into existing imaging platforms and workflows and translate the innovation into a usable product in collaboration with our technology transfer office and potential industrial partners. If successful, Smart-MRI is expected to transform breast cancer imaging by offering a contrast-free alternative to DCE-MRI without compromising diagnostic performance. By eliminating Smart-MRI is an addition to the ERC Consolidator project SAFE-MRI, focussing on the optimisation and validation of a market ready synthetic breast MRI solution, enabling widely accessible contrast-free breast MRI as a screening solution.

Location

Country

Netherlands

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Commercial, Residential

Article published date

2026-09-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project